Opaleye Management Inc. - 25 May 2021 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Issuer symbol
ETON
Transactions as of
25 May 2021
Net transactions value
-$2,064,511
Form type
4
Filing time
27 May 2021, 19:34:31 UTC
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Sale $392,380 -46,000 -1.2% $8.53 3,839,000 25 May 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale $17,060 -2,000 -1.3% $8.53 153,000 25 May 2021 By Managed Account F2
transaction ETON Common Stock, par value $0.001 per share Sale $561,335 -65,500 -1.7% $8.57 3,773,500 26 May 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale $23,996 -2,800 -1.8% $8.57 150,200 26 May 2021 By Managed Account F2
transaction ETON Common Stock, par value $0.001 per share Sale $1,030,686 -121,400 -3.2% $8.49 3,652,100 27 May 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale $39,054 -4,600 -3.1% $8.49 145,600 27 May 2021 By Managed Account F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.